PTN · Palatin Technologies Inc
$8.08
+0.40 (+5.21%)
At close · Jul 29
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“While the Company has raised funding in the past, the ability to raise funding in future periods is not considered probable, as defined under the accounting standards. As such, under the requirements of ASC 205-40, management may not consider the potential for future funding in their assessment of the Company's ability to meet its obligations for the next year. Based on the Company's current operating and development plans, including the ability to reduce or delay operating expenses that are within management's control, the Company expects that its existing cash and cash equivalents as of the date of this filing will be sufficient to enable it to fund operations through the next twelve months following the issuance of the financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$14.38M
Shares
1.78M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
$17.3M
-41.8%
FY2025
Gross Margin
97.83%
+6.4pp
FY2024
Operating Margin
-501.02%
+167.7pp
FY2024
Diluted EPS
-$32.15
+68.2%
FY2025
Operating Cash Flow
-$21.31M
+32.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $4.49M | $4.85M | $1.47M | -$188.6K | $117.99K | $60.3M | $67.13M | $67.13M | $0 | — | — | $10.36K | $73.74K | $1.48M | $14.18M | |
| — | — | $97.64K | $418.47K | $217.53K | $147.84K | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | — | $4.39M | $4.44M | $1.25M | -$336.44K | $117.99K | — | — | — | — | — | — | — | — | — | — | |
| — | — | 97.83% | 91.38% | 85.19% | — | 100% | — | — | — | — | — | — | — | — | — | — | |
| $12.33M | $14.9M | $22.4M | $22.63M | $21.33M | $12.93M | $13.96M | $14.86M | $32.57M | $32.57M | $43.07M | $24.56M | $10.83M | $10.53M | $13.81M | $10.38M | $12.29M | |
| — | — | — | — | $16.51M | $17.34M | $9.77M | $9.7M | $8.64M | $8.64M | $6.18M | $5.68M | $4.96M | $5.07M | $5.05M | $4.75M | $4.9M | |
| $7.45M | $7.81M | $12.27M | $15.29M | $16.51M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $258.92K | $339.08K | $288.33K | $126.67K | $51.12K | $64.2K | $58.64K | $56.57K | $33.05K | $43.05K | $117.59K | $111.91K | $111.84K | $949.54K | $1.14M | $1.27M | |
| $19.4M | $17.46M | $26.99M | $37.31M | $38.06M | $33.2M | -$23.61M | $24.56M | $41.21M | $41.21M | $49.25M | $30.24M | $15.79M | $15.6M | $18.86M | $15.13M | $17.2M | |
| — | $9.22M | $9.22M | $9.11M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$6.52M | -$17.46M | -$22.5M | -$32.46M | -$36.59M | -$33.38M | -$23.61M | $35.74M | $25.93M | $25.93M | -$49.25M | -$17.29M | -$15.79M | -$15.59M | -$18.79M | -$13.65M | -$3.01M | |
| — | — | -501.02% | -668.75% | -2491.63% | — | -20007.61% | 59.28% | 38.62% | 38.62% | — | — | — | -150421.39% | -25476.54% | -925.37% | -21.26% | |
| — | -$17.2M | -$22.16M | -$32.17M | -$36.46M | -$33.33M | -$23.54M | $35.8M | $25.98M | $25.96M | -$49.21M | -$17.17M | -$15.68M | -$15.47M | -$17.84M | -$12.52M | -$1.74M | |
| $7255 | $15.03K | $17.11K | $20.01K | $29.68K | $23.44K | $20.14K | $417.56K | $1.45M | $1.45M | $2.51M | $661.7K | $6211 | $8411 | $10.41K | $10.61K | $13.17K | |
| $7903 | — | — | — | — | $23.57K | $1.2M | $446.27K | $310.66K | $310.66K | $50.23K | $35.44K | $18.92K | $42.73K | $32.13K | $99.26K | $141.64K | |
| $270.13K | $152.59K | -$7.24M | $3.75M | $390.15K | -$212.39K | $1.18M | $28.71K | -$1.14M | -$1.14M | -$2.46M | -$910.91K | $12.71K | -$7.03M | $463.97K | $200.07K | $223.47K | |
| — | — | — | -$32.22M | -$36.2M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $0 | -$4.67M | $0 | — | $0 | $0 | $82.5K | $82.5K | $0 | -$531.51K | -$1.85M | -$1.75M | -$1.07M | -$637.39K | -$998.41K | |
| $28.36M | $17.3M | $29.7M | $36.2M | -$36.2M | -$33.6M | -$22.43M | $35.77M | $24.7M | $24.7M | -$51.71M | -$17.67M | -$13.93M | -$20.86M | -$17.25M | -$12.82M | -$1.79M | |
| — | — | 661.46% | 745.83% | -2465.06% | — | -19006.88% | 59.32% | 36.8% | 36.8% | — | — | — | -201352.9% | -23398.58% | -868.61% | -12.64% | |
| — | — | — | — | — | — | -$22.43M | $35.77M | $24.7M | $24.7M | -$51.71M | -$17.67M | -$13.93M | -$20.86M | -$17.25M | -$12.84M | -$1.77M | |
| USD/shares | — | — | -$2.02 | -$2.21 | — | — | -$0.10 | $0.17 | $0.12 | $0.12 | -$0.33 | -$0.15 | -$0.13 | -$0.21 | -$0.49 | -$0.64 | -$0.18 |
| USD/shares | — | -$32.15 | -$101.16 | — | — | — | -$0.10 | $0.16 | $0.12 | $0.12 | -$0.33 | — | — | — | — | — | — |
| shares | — | — | 14.7M | 10.89M | — | 236.65M | 234.68M | 207.67M | 198.1M | 198.1M | 156.55M | 121.01M | 106.68M | 97.62M | 34.9M | 20.08M | 9.86M |
| shares | — | 538.35K | 293.95K | — | — | 236.65M | 234.68M | 217.13M | 207.01M | 207.01M | 156.55M | 121.01M | 106.68M | 97.62M | 34.9M | 20.08M | 9.86M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
2.22×
Peer median 0.04×
Peer medians compare against the 217 similar-size Biotechnology companies (of 522 listed).